Dr. Joshua Mendell attained his undergraduate degree in Biology at Cornell University in 1996 and completed an M.D.-Ph.D degree at the Johns Hopkins School of Medicine in 2003. In 2004, Dr. Mendell established a research group at Johns Hopkins focused on the regulation and function of noncoding RNAs in normal physiology and in diseases such as cancer. In particular, the Mendell laboratory has devoted significant effort towards elucidating functions of the microRNA (miRNA) pathway. The Mendell research group has been at the forefront of defining miRNA functions in normal physiology and in cancer in vivo. Dr. Mendell’s research group provided one of the first demonstrations that miRNAs function as components of critical oncogenic and tumor suppressor pathways and that miRNAs represent potent and non-toxic anti-cancer therapeutic agents when delivered systemically. Dr. Mendell has been the recipient of several awards including being named the Outstanding Young Scientist in the State of Maryland in 2007 and a HHMI Early Career Scientist in 2009. In 2010, Dr. Mendell received the AACR Award for Outstanding Achievement in Cancer Research. In 2011, Dr. Mendell received a Rising Stars Award from the Cancer Prevention and Research Institute of Texas and relocated his laboratory to UT Southwestern Medical Center in Dallas where he is currently a Professor of Molecular Biology.
« Go Back